Major trial launches for debilitating muscle disease
NCT ID NCT07486934
Summary
This study is testing an investigational drug called DYNE-101 in adults with myotonic dystrophy type 1, a genetic disorder that causes progressive muscle weakness and stiffness. About 150 participants will receive either the drug or a placebo for 48 weeks to see if it improves muscle function, mobility, and daily activities. The goal is to see if the treatment can help control the disease and slow its progression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DM1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.